Fremanezumab reduces migraine frequency in children and adolescents with episodic migraine
1. In this randomized controlled trial involving pediatric patients, fremanezumab led to greater reductions in the number of migraine days...
1. In this randomized controlled trial involving pediatric patients, fremanezumab led to greater reductions in the number of migraine days...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.